For investors
The Biotts scientists and inventors team developed the first on the world’s and unique technology that allows transport through the skin hydrophilic, lipophilic, large molecules, proteins and antibodies. MTC-Y technology is a revolution in the global pharmaceutical market. What is more Biotts is the first biotechnology company in Central Europe that creates proprietary preparations and drug formulas based on extracts of natural origin and proprietary carriers of active substances that increase their bioavailability. Patented proprietary carriers of active substances can also be used as a transport system for commonly used oncological, anti-inflammatory and analgesic drugs, increasing their targeted effects by up to 10 times, reducing the drug dose by 10 times and radically minimising the side effects of therapy.